Unlocking the potential of
genomic medicine

SEC Filing Details

Document Details

Form
Filing Date
Oct 18, 2017
Document Date
Oct 17, 2017
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Aevi Genomic Medicine
Issuer
Aevi Genomic Medicine, Inc.
Filer
GANTZ WILBUR H